1. Home
  2. YRD vs BNR Comparison

YRD vs BNR Comparison

Compare YRD & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yiren Digital Ltd.

YRD

Yiren Digital Ltd.

HOLD

Current Price

$3.86

Market Cap

315.4M

Sector

Finance

ML Signal

HOLD

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$26.31

Market Cap

322.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YRD
BNR
Founded
2012
2014
Country
China
China
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
315.4M
322.1M
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
YRD
BNR
Price
$3.86
$26.31
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
46.7K
11.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
11.20%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$136.32
Revenue Next Year
N/A
N/A
P/E Ratio
$1.86
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.54
$2.18
52 Week High
$8.74
$41.72

Technical Indicators

Market Signals
Indicator
YRD
BNR
Relative Strength Index (RSI) 49.67 44.30
Support Level $3.80 $7.99
Resistance Level $4.40 $41.40
Average True Range (ATR) 0.16 1.95
MACD 0.03 -0.97
Stochastic Oscillator 64.00 27.86

Price Performance

Historical Comparison
YRD
BNR

About YRD Yiren Digital Ltd.

Yiren Digital Ltd is an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. Its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

Share on Social Networks: